TransMedics Group, Inc. TMDX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from TransMedics Group, Inc.’s reported figures.
Based on trailing twelve months.
The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about TransMedics Group, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TransMedics Group, Inc.'s return on equity?
- TransMedics Group, Inc. (TMDX) reported return on equity of 45.2% in Q1 2026.
- How has TransMedics Group, Inc.'s return on equity changed year-over-year?
- TransMedics Group, Inc.'s return on equity increased by 96.7% year-over-year, from 23% to 45.2%.
- What is the long-term trend for TransMedics Group, Inc.'s return on equity?
- Over 4 years (2020 to 2025), TransMedics Group, Inc.'s return on equity has grown at a 10.6% compound annual growth rate (CAGR), from -36.3% to 54.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.